Warrior ("If Winter Comes" No. 5)

AJ was really sleepy this morning and has been feeling a little bit groggy. Not strange due to all the drugs that are in his body on top of the chemo.

His white blood cell count went up tonight after he got a shot to boost them. It went from a 2  to 6.5—the nurse said that I would probably have like an 8—but the 6.5 is a false number that will go down. They are going to keep giving him the injection every day until its stabilizes. It will not boost his red blood cell count so its still very likely that he will still need a blood transfusion. I have to ask the nurse how that is done.

One little stupid episode of rigors came this afternoon, it was short and AJ got valium that made it stop really quick and then he had a little bit of fever, but that is it.

Tonight he is just feeling a little bit weak, who wouldn't after laying in bed for 3 weeks!!!

He will stay in hospital until his white blood cell count goes down (as a reaction of the chemo) and then starts going back up again. That is reassuring that they are not in a hurry to sign him out and send him home.

This blog follows the journey undertaken by my husband, by me, and by our family as my husband battles a disease we never saw coming: He was diagnosed with a rare subtype of T-cell non-Hodgkin's lymphoma known as Anaplastic Large Cell Lymphoma (ALK+) at the age of 32.

Photo by John Nyboer

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap